Clinical factors are significant predictors of outcome post intra-arterial therapy for acute ischaemic stroke: A review

Journal of Neuroradiology

Volumn 40, Issue 5, 2013, Pages 315-325

  Lee, Wei I ^a   Mitchell, Peter ^b   Dowling, Richard ^b   Yan, Bernard ^b,c  

^a AUSTIN HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Acute ischaemic stroke; Intra arterial therapy; Recanalisation

Indexed keywords

ABCIXIMAB; ALTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST; PLACEBO; PROUROKINASE; RETEPLASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; FIBRINOLYTIC AGENT;

AGE; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COMORBIDITY; DIABETES MELLITUS; FIBRINOLYTIC THERAPY; FLOW RESTORATION DEVICE; GLASGOW COMA SCALE; HUMAN; MECHANICAL CLOT RETRIEVAL DEVICE; MECHANICAL THROMBECTOMY; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NEUROLOGICAL THERAPEUTIC DEVICE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROGNOSIS; REVIEW; AGE DISTRIBUTION; CEREBRAL REVASCULARIZATION; INTRAARTERIAL DRUG ADMINISTRATION; OUTCOME ASSESSMENT; PREVALENCE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX RATIO; STATISTICS AND NUMERICAL DATA; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

AGE DISTRIBUTION; BRAIN ISCHEMIA; CEREBRAL REVASCULARIZATION; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRA-ARTERIAL; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84888287822     PISSN: 01509861     EISSN: 17730406     Source Type: Journal    
DOI: 10.1016/j.neurad.2013.09.002     Document Type: Review

References (66)

1. Jauch E.C., Saver J.L., Adams H.P., et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013, 44(3):870-947.
2. Tong D., Reeves M.J., Hernandez A.F., et al. Times from symptom onset to hospital arrival in the Get with the Guidelines--Stroke Program 2002 to 2009: temporal trends and implications. Stroke 2012, 43(7):1912-1917.
3. Bhatia R., Hill M.D., Shobha N., et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010, 41(10):2254-2258.
4. Rha J.H., Saver J.L. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007, 38(3):967-973.
5. Higashida R.T., Furlan A.J., Roberts H., et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003, 34(8):e109-e137.
6. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282(21):2003-2011.
7. The penumbra pivotal stroke trial Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009, 40(8):2761-2768.
8. Smith W.S., Sung G., Starkman S., et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005, 36(7):1432-1438.
9. Broderick J.P., Palesch Y.Y., Demchuk A.M., et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013, 368(10):893-903.
10. Wechsler L.R., Roberts R., Furlan A.J., et al. Factors influencing outcome and treatment effect in PROACT II. Stroke 2003, 34(5):1224-1229.
11. Ogawa A., Mori E., Minematsu K., et al. Randomized trial of intraarterial infusion of urokinase within 6hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007, 38(10):2633-2639.
12. Saver J.L., Jahan R., Levy E.I., et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 2012, 380(9849):1241-1249.
13. Nogueira R.G., Lutsep H.L., Gupta R., et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012, 380(9849):1231-1240.
14. Lisboa R.C., Jovanovic B.D., Alberts M.J. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 2002, 33(12):2866-2871.
15. Rouchaud A., Mazighi M., Labreuche J., et al. Outcomes of mechanical endovascular therapy for acute ischemic stroke: a clinical registry study and systematic review. Stroke 2011, 42(5):1289-1294.
16. Costalat V., Machi P., Lobotesis K., et al. Rescue, combined, and stand-alone thrombectomy in the management of large vessel occlusion stroke using the solitaire device: a prospective 50-patient single-center study: timing, safety, and efficacy. Stroke 2011, 42(7):1929-1935.
17. Raoult H., Eugene F., Ferre J.C., et al. Prognostic factors for outcomes after mechanical thrombectomy with solitaire stent. J Neuroradiol 2013, 10.1016/j.neurad.2013.04.001.
18. Pereira V.M., Gralla J., Davalos A., et al. Prospective, multicenter, single-arm study of mechanical thrombectomy using solitaire flow restoration in acute ischemic stroke. Stroke 2013, 10.1161/strokeaha.113.001232.
19. Zaidat O.O., Lazzaro M.A., Liebeskind D.S., et al. Revascularization grading in endovascular acute ischemic stroke therapy. Neurology 2012, 79(13 Suppl.1):S110-S116.
20. Ciccone A., Valvassori L., Nichelatti M., et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013, 368(10):904-913.
21. Jin K., Minami M., Xie L., et al. Ischemia-induced neurogenesis is preserved but reduced in the aged rodent brain. Aging Cell 2004, 3(6):373-377.
22. Anderson K.J., Scheff S.W., DeKosky S.T. Reactive synaptogenesis in hippocampal area CA1 of aged and young adult rats. J Comp Neurol 1986, 252(3):374-384.
23. White H.D., Barbash G.I., Califf R.M., et al. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation 1996, 94(8):1826-1833.
24. Hobson R.W., Howard V.J., Roubin G.S., et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 2004, 40(6):1106-1111.
25. Bhatnagar P., Sinha D., Parker R.A., Guyler P., O'Brien A. Intravenous thrombolysis in acute ischaemic stroke: a systematic review and meta-analysis to aid decision making in patients over 80years of age. J Neurol Neurosurg Psychiatry 2011, 82(7):712-717.
26. European Stroke Organisation (ESO) Executive Committee Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008, 25(5):457-507.
27. Qureshi A.I., Suri M.F., Georgiadis A.L., Vazquez G., Janjua N.A. Intra-arterial recanalization techniques for patients 80years or older with acute ischemic stroke: pooled analysis from 4 prospective studies. AJNR Am J Neuroradiol 2009, 30(6):1184-1189.
28. Kim D., Ford G.A., Kidwell C.S., et al. Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80years. AJNR Am J Neuroradiol 2007, 28(1):159-163.
29. Nogueira R.G., Liebeskind D.S., Sung G., et al. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009, 40(12):3777-3783.
30. Natarajan S.K., Karmon Y., Snyder K.V., et al. Prospective acute ischemic stroke outcomes after endovascular therapy: a real-world experience. World Neurosurg 2010, 74(4-5):455-464.
31. Stead L.G., Gilmore R.M., Bellolio M.F., Rabinstein A.A., Decker W.W. Percutaneous clot removal devices in acute ischemic stroke: a systematic review and meta-analysis. Arch Neurol 2008, 65(8):1024-1030.
32. Mazighi M., Meseguer E., Labreuche J., Amarenco P. Bridging therapy in acute ischemic stroke: a systematic review and meta-analysis. Stroke 2012, 43(5):1302-1308.
33. Setacci C., de Donato G., Chisci E., et al. Is carotid artery stenting in octogenarians really dangerous?. J Endovasc Ther 2006, 13(3):302-309.
34. Werner M., Bausback Y., Braunlich S., et al. Anatomic variables contributing to a higher periprocedural incidence of stroke and TIA in carotid artery stenting: single center experience of 833 consecutive cases. Catheter Cardiovasc Interv 2012, 80(2):321-328.
35. Batchelor W.B., Anstrom K.J., Muhlbaier L.H., et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol 2000, 36(3):723-730.
36. Appleby C.E., Ivanov J., Mackie K., Dzavik V., Overgaard C.B. In-hospital outcomes of very elderly patients (85years and older) undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2011, 77(5):634-641.
37. Saver J.L. Time is brain-quantified. Stroke 2006, 37(1):263-266.
38. Zivin J.A. Factors determining the therapeutic window for stroke. Neurology 1998, 50(3):599-603.
39. Lees K.R., Bluhmki E., von Kummer R., et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010, 375(9727):1695-1703.
40. Khatri P., Abruzzo T., Yeatts S.D., Nichols C., Broderick J.P., Tomsick T.A. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009, 73(13):1066-1072.
41. Eckert B., Kucinski T., Pfeiffer G., Groden C., Zeumer H. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc Dis 2002, 14(1):42-50.
42. Mazighi M., Serfaty J.M., Labreuche J., et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009, 8(9):802-809.
43. Becktepe J.S., You S.J., Berkefeld J., Neumann-Haefelin T., Singer O.C. Clinical outcome after mechanical recanalization as mono- or adjunctive therapy in acute stroke: importance of time to recanalization. Cerebrovasc Dis 2011, 32(3):211-218.
44. Sacks D., Black C.M., Cognard C., et al. Multisociety Consensus Quality Improvement Guidelines for Intraarterial Catheter-directed Treatment of Acute Ischemic Stroke, from the American Society of Neuroradiology, Canadian Interventional Radiology Association, Cardiovascular and Interventional Radiological Society of Europe, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, European Society of Minimally Invasive Neurological Therapy, and Society of Vascular and Interventional Neurology. AJNR Am J Neuroradiol 2013, 34(4):E0.
45. Lazzaro M.A., Novakovic R.L., Alexandrov A.V., et al. Developing practice recommendations for endovascular revascularization for acute ischemic stroke. Neurology 2012, 79(13 Suppl.1):S243-S255.
46. Janjua N. Use of neuroimaging to guide the treatment of patients beyond the 8-hour time window. Neurology 2012, 79(13 Suppl.1):S95-S99.
47. Jovin T.G., Liebeskind D.S., Gupta R., et al. Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8hours from time last seen well: retrospective multicenter analysis of 237 consecutive patients. Stroke 2011, 42(8):2206-2211.
48. Abou-Chebl A. Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke 2010, 41(9):1996-2000.
49. Attye A., Boncoeur-Martel M.P., Maubon A., et al. [Diffusion-Weighted Imaging infarct volume and neurologic outcomes after ischemic stroke]. J Neuroradiol 2012, 39(2):97-103.
50. Knoepfli A.S., Sekoranja L., Bonvin C., et al. Evaluation of perfusion CT and TIBI grade in acute stroke for predicting thrombolysis benefit and clinical outcome. J Neuroradiol 2009, 36(3):131-137.
51. Rogers D.C., Campbell C.A., Stretton J.L., Mackay K.B. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 1997, 28(10):2060-2065. [discussion 2066].
52. Tong D.C., Yenari M.A., Albers G.W., O'Brien M., Marks M.P., Moseley M.E. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5hours) ischemic stroke. Neurology 1998, 50(4):864-870.
53. Wahlgren N., Ahmed N., Eriksson N., et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008, 39(12):3316-3322.
54. Levy E.I., Firlik A.D., Wisniewski S., et al. Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intra-arterial thrombolytic therapy: a meta-analytical approach. Neurosurgery 1999, 45(3):539-545. [discussion 538-45].
55. Costalat V., Lobotesis K., Machi P., et al. Prognostic factors related to clinical outcome following thrombectomy in ischemic stroke (RECOST study). 50 patients prospective study. Eur J Radiol 2012, 81(12):4075-4082.
56. Nagel S., Schellinger P.D., Hartmann M., et al. Therapy of acute basilar artery occlusion: intraarterial thrombolysis alone vs bridging therapy. Stroke 2009, 40(1):140-146.
57. Arnold M., Nedeltchev K., Schroth G., et al. Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004, 75(6):857-862.
58. Kidwell C.S., Saver J.L., Carneado J., et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 2002, 33(3):717-724.
59. Restrepo L., Bang O.Y., Ovbiagele B., et al. Impact of hyperlipidemia and statins on ischemic stroke outcomes after intra-arterial fibrinolysis and percutaneous mechanical embolectomy. Cerebrovasc Dis 2009, 28(4):384-390.
60. Yang X.D., Zhao Y.S., Li Y.F., Guo X.H. Medical comorbidities at admission is predictive for 30-day in-hospital mortality in patients with acute myocardial infarction: analysis of 5161 cases. J Geriatr Cardiol 2011, 8(1):31-34.
61. Goldstein L.B., Samsa G.P., Matchar D.B., Horner R.D. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke 2004, 35(8):1941-1945.
62. Flint A.C., Cullen S.P., Faigeles B.S., Rao V.A. Predicting long-term outcome after endovascular stroke treatment: the totaled health risks in vascular events score. AJNR Am J Neuroradiol 2010, 31(7):1192-1196.
63. Arnold M., Mattle S., Galimanis A., et al. Impact of admission glucose and diabetes on recanalization and outcome after intra-arterial thrombolysis for ischaemic stroke. Int J Stroke 2012, 10.1111/j.1747-4949.2012.00879.x.
64. Galimanis A., Jung S., Mono M.L., et al. Endovascular therapy of 623 patients with anterior circulation stroke. Stroke 2012, 43(4):1052-1057.
65. Kwok C.S., Clark A., Ford G.A., et al. Association between prestroke disability and inpatient mortality and length of acute hospital stay after acute stroke. J Am Geriatr Soc 2012, 60(4):726-732.
66. Hankey G.J., Spiesser J., Hakimi Z., Bego G., Carita P., Gabriel S. Rate, degree, and predictors of recovery from disability following ischemic stroke. Neurology 2007, 68(19):1583-1587.